Published on in Vol 23, No 3 (2021): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/22453, first published .
Artificial Intelligence–Aided Precision Medicine for COVID-19: Strategic Areas of Research and Development

Artificial Intelligence–Aided Precision Medicine for COVID-19: Strategic Areas of Research and Development

Artificial Intelligence–Aided Precision Medicine for COVID-19: Strategic Areas of Research and Development

Enrico Santus   1, 2 , PhD ;   Nicola Marino   2, 3 , BSc ;   Davide Cirillo   2, 4 , PhD ;   Emmanuele Chersoni   5 , PhD ;   Arnau Montagud   4 , PhD ;   Antonella Santuccione Chadha   2, 6 , MD ;   Alfonso Valencia   4, 7 , PhD ;   Kevin Hughes   8 , MD ;   Charlotta Lindvall   9, 10 , MD, PhD

1 Division of Decision Science and Advanced Analytics, Bayer Pharmaceuticals, Whippany, NJ, United States

2 The Women's Brain Project, Zurich, Switzerland

3 Department of Medical and Surgical Sciences, Università degli Studi di Foggia, Foggia, Italy

4 Barcelona Supercomputing Center, Barcelona, Spain

5 Department of Chinese and Bilingual Studies, The Hong Kong Polytechnic University, Hong Kong, China (Hong Kong)

6 Biogen International GmbH, Baar, Switzerland

7 Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain

8 Massachusetts General Hospital, Boston, MA, United States

9 Dana-Farber Cancer Institute, Boston, MA, United States

10 Harvard Medical School, Boston, MA, United States

Corresponding Author: